LSPBio Ltd (www.lspbio.com) is to launch two innovative hyaluronic acid (HA) products, SportVis™ (ankle sprain/epicondylitis) and RenehaVis™ (knee osteoarthritis). SportVis™ contains STABHA and promises significant pain reduction, with accelerated recovery time (average seven days) in grade 1/2 ankle sprain and major grip strength improvement in epicondylitis. RenehaVis™ is dual-chambered, delivering different HA formulations via single injection. RenehaVis™ improves cushioning and elasticity and patients benefit in movement and pain relief at rest and activity. Recent data suggests durability of benefit to beyond one year with a less intrusive schedule than existing products. For more information please contact Mark Lewis (mlewis@lspbio.com)
